Literature DB >> 9034720

Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.

P Borden1, R A Heller.   

Abstract

Matrix metalloproteinases (MMPs) are enzymes with important roles in a variety of normal physiological processes; these same enzymes are also operative in a range of pathologies. The proteins known as the tissue inhibitors of matrix metalloproteinases (TIMPs) act to limit the enzymatic function of the MMPs. MMPs and TIMPs can be divided into two groups with respect to gene expression: the majority exhibit inducible expression and a small number are produced constitutively or are expressed at very low levels and are not inducible. Among the agents that induce MMP and TIMP production are the inflammatory cytokines TNF alpha and IL1 beta. A marked cell type specificity is a hallmark of both MMP and TIMP gene expression (i.e., a limited number of cell types can be induced to make these proteins). An analysis of the control elements in the promoter regions of these proteins reveals a correlation between the presence of both AP-1 and Ets binding sites and inducible expression. The chromosomal locations of most of the MMPs and TIMPs have been verified; these data will provide the basis for investigations into possible correlations between mutations in these genes and disease states.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034720     DOI: 10.1615/critreveukargeneexpr.v7.i1-2.90

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  49 in total

1.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 2.  Metalloproteinases, inflammation, and rheumatoid arthritis.

Authors:  F F Mohammed; D S Smookler; R Khokha
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Variability in melanoma metalloproteinase expression profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  J Biomol Tech       Date:  2010-12

4.  Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.

Authors:  Chrysanthos Symeonidis; Eudoxia Diza; Eleni Papakonstantinou; Efimia Souliou; George Karakiulakis; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

Review 5.  Protein kinase CK2, an important regulator of the inflammatory response?

Authors:  Nishi N Singh; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

6.  Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease.

Authors:  Hyun Phil Shin; Joung Il Lee; Joo-Ho Jung; Sung-Vin Yim; Hyun Jeong Kim; Jae Myung Cha; Jong Beom Park; Kwang Ro Joo; Jae Seok Hwang; Byoung-Kuk Jang
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

7.  Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes.

Authors:  Chrysanthos Symeonidis; Eleni Papakonstantinou; Asimina Galli; Ioannis Tsinopoulos; Asimina Mataftsi; Spyridon Batzios; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-20       Impact factor: 3.117

8.  The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.

Authors:  Ben Davidson; Iris Goldberg; Liora Tell; Sophya Vigdorchik; Mark Baekelandt; Aasmund Berner; Gunnar B Kristensen; Reuven Reich; Juri Kopolovic
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

9.  Identification of CITED2 as a negative regulator of fracture healing.

Authors:  Jonathan Y Lee; Peter J Taub; Liang Wang; Amelia Clark; Ling L Zhu; Edward R Maharam; Daniel J Leong; Melissa Ramcharan; Zhengzhi Li; Zhonghou Liu; Yuan-Zheng Ma; Li Sun; Mone Zaidi; Robert J Majeska; Hui B Sun
Journal:  Biochem Biophys Res Commun       Date:  2009-07-14       Impact factor: 3.575

10.  Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways.

Authors:  Yi-Cheng Lin; Yu-Chih Liang; Ming-Thau Sheu; Yu-Chen Lin; Ming-Shium Hsieh; Tzeng-Fu Chen; Chien-Ho Chen
Journal:  Rheumatol Int       Date:  2008-03-14       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.